Skip to content
A612Assembly2021-2022 SessionSame asS2524

Decriminalize Buprenorphine Possession

Official title

“Relates to decriminalizing the possession of buprenorphine”

Sponsor Linda RosenthalAD-67+18 co-sponsorsAffects Legal
Status
In Assembly Committee
Codes
Impact
6/10
Moderate
Passage
0%

Bill progress

Step 2 of 7

In committee · Codes

What's happening

This bill decriminalizes the possession of buprenorphine by removing it from New York's controlled substances law.

Why it matters

  1. Expands access to a key addiction treatment. Buprenorphine is a medication used to treat opioid use disorder. Decriminalizing its possession can help more people access this lifesaving treatment without fear of arrest, supporting public health and harm reduction.

  2. Reduces legal risks for vulnerable populations. People who use or possess buprenorphine—sometimes without a prescription, often due to barriers in the healthcare system—will no longer face criminal charges, reducing the likelihood of incarceration and its associated harms.

  3. Shifts policy toward a public health approach. By removing buprenorphine from New York’s controlled substances law, the state signals a move away from criminalization and toward treating substance use as a health issue rather than a criminal one.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Decriminalize Buprenorphine Possession

Plain English, a few words. Used as the page title.

Sponsors

History

  1. Referred to codes
  2. Referred to codes

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

S2524Senate

Decriminalize Buprenorphine Possession

In Senate Committee · Codes · Sponsor Gustavo Rivera

Impact 6 · Moderate0% to pass

Full text

1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

612

2021-2022 Regular Sessions

IN ASSEMBLY (Prefiled)

January 6, 2021

Introduced by M. of A. L. ROSENTHAL -- read once and referred to the Committee on Codes

AN ACT to amend the penal law, in relation to decriminalizing the possession of buprenorphine

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subdivisions 5 and 8 of section 220.00 of the penal law, subdivision 5 as amended by chapter 537 of the laws of 1998 and subdivision 8 as amended by section 18 of part C of chapter 447 of the laws of 2012, are amended to read as follows:

5. "Controlled substance" means any substance listed in schedule I, II, III, IV or V of section thirty-three hundred six of the public health law other than buprenorphine and marihuana, but including concentrated cannabis as defined in paragraph (a) of subdivision four of section thirty-three hundred two of such law.

8. "Narcotic preparation" means any controlled substance listed in schedule II(b-1), III(d) or III(e) other than buprenorphine.

§ 2. This act shall take effect on the first of November next succeeding the date on which it shall have become a law.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD00318-01-1

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.